Department of Animal Biosciences, Animal Science and Nutrition, University of Guelph, Guelph, Ontario, Canada N1G 1Y2.
Department of Population Medicine, Ontario Veterinary College, University of Guelph, Guelph, Ontario, Canada N1G 1Y2.
J Dairy Sci. 2021 Jul;104(7):8188-8201. doi: 10.3168/jds.2020-19827. Epub 2021 Apr 30.
The prophylactic use of oral antimicrobials, such as neomycin, in milk replacer (MR) or whole milk is a common practice in calf-rearing that is thought to aid in preventing disease. Heavy reliance on antimicrobials is of concern not only because of the development of antimicrobial resistance, but also because of the potentially negative effects on health. The objective of this study was to investigate the effects of neomycin on calf health and growth performance. One hundred and sixty calves (approximately 3-10 d of age), distributed across 2 experimental periods, were stratified by body weight (BW) and serum total protein, and assigned to 1 of 3 treatments: control (CON; nonmedicated MR, n = 60), short-term antibiotic (ST; neomycin mixed in MR from d 1-14, n = 50), or long-term antibiotic (LT; neomycin in MR from d 1-28, n = 50). Arrival BW (47.69 ± 0.87 kg) and serum total protein (5.67 ± 0.09 g/dL) were not different between treatment groups. Neomycin in ST and LT was dosed in MR at a rate of 20 mg/kg of BW and was adjusted weekly according to BW. Calf BW was measured weekly for 49 d, and health indicators (fecal score, attitude score, respiratory score, and rectal temperature), MR intake, starter intake, and the use of additional electrolytes and antimicrobials were recorded daily. Calves in the CON group experienced a higher proportion of days with diarrhea (20.32 ± 0.02%) compared with ST (14.70 ± 0.02%) or LT (13.80 ± 0.02%) calves, as well as longer bouts of diarrhea (7.45 ± 0.38 d, 5.69 ± 0.46 d, and 5.62 ± 0.45 d for CON, ST, and LT calves, respectively). Calves in the CON group also experienced higher fecal scores (score of 0.64 ± 0.04) than ST (score of 0.53 ± 0.04) or LT (score of 0.49 ± 0.04) calves, especially at d 7. However, no differences were observed in other health-related measures. The time to reach first diarrhea and first respiratory illness was not different between treatments, nor was the time to recover from respiratory illness. The time to intervention with additional electrolytes or antimicrobials was not different between treatment groups. Furthermore, growth performance, feed intake, and feed conversion ratio were not different. No differences were found when comparing ST and LT, except in the defined daily dose of total antimicrobials received. Calves in the LT group received a higher overall dose than ST calves, and both ST and LT calves received a higher dose than CON calves, which received no prophylactic antimicrobials. Given that there were no differences in performance variables and no additional health benefits aside from reduced fecal scores in calves fed neomycin, current practices involving the use of antimicrobials on dairy and veal operations need to be considered more prudently.
预防性使用口服抗生素,如新霉素,在代乳料(MR)或全脂奶中是犊牛饲养中的常见做法,被认为有助于预防疾病。过度依赖抗生素不仅令人担忧,因为这会导致抗生素耐药性的产生,而且还可能对健康产生潜在的负面影响。本研究的目的是调查新霉素对犊牛健康和生长性能的影响。160 头犊牛(约 3-10 日龄),按体重(BW)和血清总蛋白分为 2 个实验期,分为 3 个处理组之一:对照组(CON;未用药的 MR,n=60)、短期抗生素(ST;新霉素混合在 MR 中,从第 1 天到第 14 天,n=50)或长期抗生素(LT;从第 1 天到第 28 天,n=50)。在处理组之间,到达 BW(47.69±0.87kg)和血清总蛋白(5.67±0.09g/dL)没有差异。ST 和 LT 中的新霉素以 20mg/kg BW 的剂量添加到 MR 中,并根据 BW 每周进行调整。犊牛 BW 在 49 天内每周测量一次,记录健康指标(粪便评分、态度评分、呼吸评分和直肠温度)、MR 摄入量、开食料摄入量以及额外电解质和抗生素的使用情况。与 ST(14.70±0.02%)或 LT(13.80±0.02%)相比,CON 组的犊牛腹泻天数比例更高(20.32±0.02%),腹泻持续时间也更长(CON、ST 和 LT 犊牛分别为 7.45±0.38d、5.69±0.46d 和 5.62±0.45d)。CON 组的犊牛粪便评分(评分 0.64±0.04)也高于 ST(评分 0.53±0.04)或 LT(评分 0.49±0.04)组的犊牛,尤其是在第 7 天。然而,在其他与健康相关的措施方面没有观察到差异。首次腹泻和首次呼吸道疾病的时间在处理之间没有差异,从呼吸道疾病中恢复的时间也没有差异。处理组之间添加电解质或抗生素的干预时间没有差异。此外,生长性能、饲料摄入量和饲料转化率没有差异。在 ST 和 LT 之间除了接受的总抗生素日剂量外,没有发现其他差异。LT 组的犊牛接受的总剂量高于 ST 组,而 ST 和 LT 组的犊牛接受的剂量均高于 CON 组,后者未接受预防性抗生素。鉴于在性能变量方面没有差异,并且除了粪便评分降低之外,没有其他额外的健康益处,因此需要更谨慎地考虑奶牛和小牛肉养殖场目前使用抗生素的做法。